skip to main content

Pancreatic Cancer

Pancreatic Survival Rates Improving

Since 2013, survival rates for pancreatic cancer have been slowly going up, making pancreatic cancer doctors hopeful that the next five years will see even bigger increases in survival rates -- as well as better care. University of Michigan researchers believe the immune system is the answer to overcoming pancreatic cancer.

Pancreatic Tumor-associated Macrophages Resist Chemotherapy

Gemcitabine, a front-line chemotherapy drug given to patients with pancreatic cancer, is made less effective because similar compounds released by tumor-associated immune cells block the drug’s action, research led by the University of Michigan Rogel Cancer Center found.

Why Every Pancreatic Cancer Patient Should Consider Genetic Testing

It now appears that as many as 1 in 10 patients diagnosed with pancreatic cancer carry a genetic alteration associated with an increased risk of pancreatic or other cancer types. If family members learn they may be at risk for pancreatic or other cancer types, they have more opportunities to take action.

Treatment Targets Tough Cancers by Bathing Tumors in Chemo

The biggest threat cancer poses happens when it spreads throughout the body -- and when it has spread to the lining of the abdominal cavity it's particularly tricky. Once these advanced cancers have entered that area, they’re notoriously difficult to treat. Surgery alone is rarely successful, and traditional chemotherapy yields limited results, but a treatment called HIPEC offers hope.

The Act of Sharing

Four years after being diagnosed with stage 4 pancreatic cancer, Rose Mary Worthen faces every day with hope. Her passion for art led her to create inspirational charms -- or stones -- that she shares with others. Sharing hope, sharing joy, sharing laughter keeps her going.

Pages